Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,037,646
in 4 filings

Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-26 Cohen Fred E Director Grant or award +69,339 $9.54 $661K 69,339
2023-07-25 Robinson James A. Jr. Director Grant or award · Stock Option (right to buy) +20,000 20,000
2023-07-25 Robinson James A. Jr. Director Grant or award · Stock Option (right to buy) +20,000 20,000
2023-06-08 Schoenberg Mark Chief Medical Officer Grant or award · Restricted Stock Units +30,000 30,000
2023-01-31 Barrett Elizabeth A. Chief Executive Officer Option exercise +5,000 313,358
2023-01-31 Barrett Elizabeth A. Chief Executive Officer Option exercise +13,333 326,691
2023-01-31 Barrett Elizabeth A. Chief Executive Officer Option exercise · Restricted Stock Units −5,000 0
2023-01-31 Barrett Elizabeth A. Chief Executive Officer Option exercise · Restricted Stock Units −13,333 13,334
2023-01-31 Barrett Elizabeth A. Chief Executive Officer Grant or award · Restricted Stock Units +75,000 75,000
2023-01-31 Barrett Elizabeth A. Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +125,000 125,000
2023-01-31 Barrett Elizabeth A. Chief Executive Officer Grant or award · Performance Stock Units +100,000 100,000
2023-01-31 Kim Dong Chief Financial Officer Grant or award · Restricted Stock Units +10,000 10,000
2023-01-31 Kim Dong Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +38,000 38,000
2023-01-31 Smith Jason Drew General Counsel Option exercise +833 13,009
2023-01-31 Smith Jason Drew General Counsel Sale −409 $10.12 $4K 12,600
2023-01-31 Smith Jason Drew General Counsel Option exercise +2,500 15,100
2023-01-31 Smith Jason Drew General Counsel Sale −1,227 $10.12 $12K 13,873
2023-01-31 Smith Jason Drew General Counsel Option exercise · Restricted Stock Units −833 834
2023-01-31 Smith Jason Drew General Counsel Option exercise · Restricted Stock Units −2,500 5,000
2023-01-31 Smith Jason Drew General Counsel Grant or award · Restricted Stock Units +20,000 20,000

Page 10 of 13 · 244 trades